Skip to main content
PFIZER INC logo

PFIZER INC — Investor Relations & Filings

Ticker · PFE ISIN · US7170811035 LEI · 765LHXWGK1KXCLTFYQ30 US Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 6,457 across all filing types
Latest filing 2026-06-18 Board/Management Inform…
Country US United States of America
Listing US PFE

About PFIZER INC

https://www.pfizer.com/

Pfizer Inc. is a research-based biopharmaceutical company that discovers, develops, manufactures, and distributes a broad portfolio of medicines and vaccines. The company's core mission is to apply science and its global resources to create therapies that significantly extend and improve human lives. Its work spans multiple therapeutic areas, including internal medicine, inflammation, immunology, and oncology. Pfizer is recognized for its extensive research and development pipeline, which has produced widely used treatments and preventative therapies, such as vaccines and antivirals for infectious diseases. The company collaborates with the global healthcare community to deliver innovative solutions and address unmet medical needs.

Recent filings

Filing Released Lang Actions
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K, a current report filed pursuant to the Securities Exchange Act of 1934. It contains a disclosure of a management change (CFO transition), reaffirmation of fiscal year 2026 guidance, and includes forward-looking statements and risk factors. The document is a current report updating investors on significant corporate events and not a full annual or quarterly financial report. Form 8-Ks commonly serve as updates on significant corporate events and disclosures rather than detailed financial reporting or conference call transcripts. Since it reports management changes and related updates but not a detailed full or interim financial report, it aligns closely with Board/Management Information filings or Regulatory Filings. However, the form explicitly discloses a CFO transition and related reaffirmation of guidance, which is a management information update. Thus, the filing is best categorized as Board/Management Information (MANG). Confidence is high given the explicit mention of CFO transition and reaffirmation of guidance in a Form 8-K.
2026-06-18 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated June 18, 2026. The content focuses on the resignation of the CFO Dave Denton effective August 15, 2026, and the appointment of an interim CFO, Cecile Guegan. This is a management change announcement, specifically concerning senior management roles. It includes a press release as an exhibit related to this announcement. There are no financial statements or financial performance details presented in this document. This fits the category of Board/Management Information (MANG) which covers announcements of changes in senior management.
2026-06-18 English
11-K
Annual Report Classification · 95% confidence The document is a United States Securities and Exchange Commission Form 11-K, which is an annual report for employee stock purchase, savings, and similar plans. It is titled as an Annual Report for the fiscal year ended December 31, 2025, and contains detailed financial statements of the Pfizer Savings Plan for Employees Resident in Puerto Rico, including independent auditor's report, statements of net assets available for plan benefits, statement of changes in net assets, and notes to the financial statements. The document includes substantive financial data and analysis for a full fiscal year period. The 11-K is a specialized annual report filed by employee benefit plans but is not a general company Annual Report (10-K). However, it is an official annual report document covering financial performance specific to the plan. Given the specificity of definitions provided, the best matching category is Annual Report (10-K) for official yearly reports covering full financial performance. This is consistent as 11-K is a type of annual report form filed with SEC. The document is not a brief announcement, certification, or standalone audit report, but a substantive audited annual filing. FY 2025
2026-06-16 English
11-K
Annual Report Classification · 95% confidence The document is identified as "FORM 11-K" filed with the SEC, which is specifically an annual report for employee stock purchase, savings, and similar plans as required under Section 15(d) of the Securities Exchange Act of 1934. It covers the fiscal year ended December 31, 2025. The contents include audited financial statements, a report of an independent auditor, notes to financial statements, and supplemental schedules specific to the Pfizer Savings Plan. This type of form 11-K is a comprehensive annual report on employee benefit plans, which is distinct from a corporate Annual Report (10-K), Earnings Release, or any other specified filings. Given the form mentioned and the detailed financial statements included, this filing best fits the definition of an Annual Report but specifically for employee benefit plans under SEC rules. As per standard SEC classifications, form 11-K files are a type of Annual Report distinct from 10-K and are audited financial reports of employee benefit plans. Therefore, the best classification under provided categories is Annual Report (10-K) as it covers comprehensive financial information and management discussion for a defined fiscal year, aligned with SEC annual report requirements for employee benefit plans. FY 2025
2026-06-16 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-05-12 English
Regulatory Filings 2026
Regulatory Filings
2026-05-12 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.